TMCnet News
B-Cell Lymphoma Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H2 2017 - ResearchAndMarkets.comThe "B-Cell Lymphoma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017" report has been added to ResearchAndMarkets.com's offering. Lymphoma is a cancer type where uncontrollable growth of lymphocytes (WBCs) initiating from lymph glands or lymphatic tissue or other parts of the lymphatic system, including bone marrow, tonsils, testicles, spleen and lymph nodes. This excess growth of lymphocytes often accumulates in lymph nodes. Though this accumulation can occur in any body part, commonly affected parts are armpits, neck and groin and rarely in lungs or bones. The non- inheritable and non- contagious disease is one of the common types of cancer but can be treated with patients' life expectancy remaining quite large post- treatment. Genomic alterations in lymphocytes cause damage to the lfecycle of these cells, boosting the cell division rate or affecting the death period. However, causes for such gene changes are yet to be determined. Phases of Lymphoma cancer
Key Topics Covered: 1 Table of Contents 2 Executive Summary 3 B-Cell Lymphoma Drugs in Ongoing and Completed Trials 4 Global B-Cell Lymphoma Clinical Trial Research Trends 5 Africa B-Cell Lymphoma Clinical Trial Research Trends 6 Europe B-Cell Lymphoma Clinical Trial Research Trends 7 Western Pacific B-Cell Lymphoma Clinical Trial Research Trends 8 Eastern Mediterranean B-Cell Lymphoma Clinical Trial Research Trends 9 South East Asia B-Cell Lymphoma Clinical Trial Research Trends 10 North America B-Cell Lymphoma Clinical Trial Research Trends 11 South and Central America B-Cell Lymphoma Clinical Trial Research Trends 12 Recent Clinical Trials- Snapshots 13 Appendix For more information about this report visit https://www.researchandmarkets.com/research/stm7rh/bcell_lymphoma?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180119005598/en/ |
